GlassScriptPhysician profile
Christopher Ryan Michel
NPI 1184285181
$9,515.32
in general payments reported to CMS, 2019-2025
11 companies · $4,837 in 2025
The $4,837 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.80 · 2022: $226 · 2023: $506 · 2024: $3,934 · 2025: $4,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,378 · Travel and Lodging: $3,692 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,378.08 |
| Travel and Lodging | $3,691.80 |
| Education | $206.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,509.95 | 2022-2025 | Everest Spinal System, Aero-Ll, Mako |
| Si-Bone, INC. | $2,554.46 | 2024-2025 | |
| Globus Medical, INC. | $1,450.91 | 2024-2025 | Senza, Altera, Reline |
| Medtronic, INC. | $1,079.46 | 2023-2025 | O-Arm, Infinity Occipitocervical Upper Thoracic System, Stealthstation S8 Platform |
| Cerapedics INC. | $332.98 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Vb Spine LLC | $200.74 | 2025 | Niagara Lateral Access System, Everest Spinal System |
| Centinel Spine, LLC | $124.47 | 2025 | Prodisc L |
| Orthofix Medical, INC. | $106.65 | 2024 | 7d Surgical System |
| Nevro Corp. | $87.88 | 2024 | Senza |
| Depuy Synthes Sales INC. | $55.02 | 2024 | |
| Seapearl East, INC | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.